Concepedia

Marlene Hennessy

MH

4

Publications

135

Citations

4

H-Index

2017

Active since

Affiliations

Nektar Therapeutics (United States)(Current)

Marlene Hennessy is an author at Nektar Therapeutics (United States) specializing in tumor immunity, tumor biology, and medicine.

ORCID

Top concepts

Publications per year

2017–2021

4

Publications

4

NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy

Takahiro Miyazaki, Mekhala Maiti, Marlene Hennessy et al. · Journal for ImmunoTherapy of Cancer · 2021 · 52 citations · Full text

NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential

Takahiro Miyazaki, Irene Choi, Werner Rubas et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 46 citations · Full text

Abstract 3755: Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214

Saul Kivimäe, Marlene Hennessy, Rhoneil Pena et al. · Cancer Research · 2018 · 19 citations

, , +24

Bempegaldesleukin (<scp>BEMPEG</scp>; <scp>NKTR</scp>‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma

Marlene Hennessy, Andrew Wahba, Kumar Felix et al. · International Journal of Cancer · 2020 · 18 citations · Full text

, , +17

Rows per page

1–4 of 4